To inform about the FDA's classification of Medtronic's Harmony Delivery Catheter System recall due to a manufacturing issue.
Approach:
Recall Classification: The FDA classified the recall as Class I due to a manufacturing issue affecting specific catheter systems.
Affected Devices: The recall affects 1,881 devices distributed in the US and internationally.
Device Function: The Harmony Delivery Catheter System is used for placing the Harmony transcatheter pulmonary valve in patients with severe pulmonary regurgitation.
Risks Identified: Potential risks include distal tip detachment, prolonged procedure time, tissue damage, and other complications.
Patient Guidance: Patients with an implanted Harmony valve do not require additional measures and should continue usual follow-up care.
Manufacturer Instructions: Medtronic instructed customers to quarantine and return affected devices and notify relevant parties.
Key Findings:
Manufacturing issue can increase likelihood of distal tip detachment.
Recall limited to the delivery catheter, not the implanted valve.
No serious injuries or deaths reported as of May 14, 2026.
Interpretation:
The recall highlights a significant manufacturing concern that could impact procedural safety.
Limitations:
Recall does not affect the implanted valve, limiting the scope of patient impact.
Conclusion:
Patients should remain informed but continue with standard follow-up care.
